Manufacturers Life Insurance Company, The Monte Rosa Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $100 Billion
- Q1 2025
A detailed history of Manufacturers Life Insurance Company, The transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 117,307 shares of GLUE stock, worth $539,612. This represents 0.0% of its overall portfolio holdings.
Number of Shares
117,307
Previous 117,412
0.09%
Holding current value
$539,612
Previous $814,000
33.17%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding GLUE
# of Institutions
107Shares Held
53.4MCall Options Held
69.1KPut Options Held
22.4K-
Nea Management Company, LLC Timonium, MD7.69MShares$35.4 Million3.39% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.64MShares$30.6 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA5.66MShares$26 Million1.15% of portfolio
-
Versant Venture Management, LLC San Francisco, CA5.65MShares$26 Million54.61% of portfolio
-
Baker Bros. Advisors LP New York, NY4.92MShares$22.6 Million0.27% of portfolio
About Monte Rosa Therapeutics, Inc.
- Ticker GLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,713,900
- Market Cap $215M
- Description
- Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...